This role is lab based at our Scientific Campus in Porton. The Countermeasures Development and Evaluation Centre is located there and has approximately 250 staff performing a range of research activities, including high containment level work. The department's work covers a broad range of projects involving vaccine and therapeutic discovery, evaluation, development, and research.
Eligibility and Security VettingApplicants must have a Counter Terrorism Check (CTC) security vetting clearance. To qualify for meaningful National Security Vetting checks, individuals should usually have been resident in the United Kingdom for the last three years. In exceptional circumstances, UK residency less than the outlined period may not necessarily bar you from gaining national security vetting, but applicants should contact the Vacancy Holder/Recruiting Manager listed in the advert for further advice.
AD3 Team and DivisionThe Antimicrobial Development, Discovery and Diagnostics (AD3) team sits in the Countermeasures Development, Evaluation and Preparedness Division in the Public Health Microbiology Directorate within the Chief Scientific Officer Group. Its work focuses on the discovery, development and evaluation of antimicrobial therapies directed at UKHSA priority pathogens, with a particular focus on AMR/emerging pathogens.
ResponsibilitiesThe post holder will provide specialist laboratory skills in support of the bacteriophage 'integrated pathway' programme, which is developing a phage service to support clinical use of phage in the UK, including an in‐house phage library. The post holder will also contribute towards developing novel phage susceptibility testing methods and supporting UK‐based phage manufacture.
#J-18808-Ljbffr